Hematopoietic mosaic chromosomal alterations and risk for infection among 767,891 individuals without blood cancer
Seyedeh Maryam ZekavatiD, Shu‐Hong LiniD, Alexander G. BickiD, Aoxing LiuiD, Kaavya ParuchuriiD, Md Mesbah UddiniD, Yixuan YeiD, Zhaolong YuiD, Xiaoxi LiuiD, Yoichiro KamataniiD, James P. PirruccelloiD, Akhil PampanaiD, Po‐Ru LohiD, Puja KohliiD, Steven A. McCarrolliD, Benjamin M. NealeiD, Eric A. EngelsiD, Derek W. BrowniD, Jordan W. SmolleriD, Robert C. GreeniD, Elizabeth W. KarlsoniD, Matthew S. LeboiD, Patrick T. EllinoriD, Scott T. WeissiD, Mark J. DalyiD, , Pradeep NatarajaniD
Abstract
Summary ParagraphAge is the dominant risk factor for infectious diseases, but the mechanisms linking the two are incompletely understood1,2. Age-related mosaic chromosomal alterations (mCAs) detected from blood-derived DNA genotyping, are structural somatic variants associated with aberrant leukocyte cell counts, hematological malignancy, and mortality3-11. Whether mCAs represent independent risk factors for infection is unknown. Here we use genome-wide genotyping of blood DNA to show that mCAs predispose to diverse infectious diseases. We analyzed mCAs from 767,891 individuals without hematological cancer at DNA acquisition across four countries. Expanded mCA (cell fraction >10%) prevalence approached 4% by 60 years of age and was associated with diverse incident infections, including sepsis, pneumonia, and coronavirus disease 2019 (COVID-19) hospitalization. A genome-wide association study of expanded mCAs identified 63 significant loci. Germline genetic alleles associated with expanded mCAs were enriched at transcriptional regulatory sites for immune cells. Our results link mCAs with impaired immunity and predisposition to infections. Furthermore, these findings may also have important implications for the ongoing COVID-19 pandemic, particularly in prioritizing individual preventive strategies and evaluating immunization responses.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 14
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Patterns and drivers of 43,617 mosaic chromosomal alterations in blood
David Shin-Hsiung Tang, Nolan Kamitaki, … Po‐Ru Loh·Nature GeneticsPeer-reviewed·May 19, 2026
- Geography, Ancestry, Age and Sex Shape Somatic Autosomal Mosaic Chromosomal Alterations in Blood
Jasmine Ryu Won Kang, Y Kim, … Philip Awadalla·medRxiv·Oct 19, 2025
- Genetic drivers and clinical consequences of mosaic chromosomal alterations in 1 million individuals
Kun Zhao, Yash Pershad, … Alexander G. Bick·medRxiv·Mar 5, 2025
- Mosaic chromosomal alterations in blood across ancestries via whole-genome sequencing
Yasminka A. Jakubek, Ying Zhou, … Paul Livermore Auer·bioRxiv·Nov 7, 2022
- Clonal chromosomal mosaicism and loss of chromosome Y in men are risk factors for SARS-CoV-2 vulnerability in the elderly
Luis Alberto Pérez Jurado, Alejandro Cáceres, … Juan R. González·medRxiv·Apr 19, 2020
- Mutation rates and fitness consequences of mosaic chromosomal alterations in blood
Caroline J. Watson, Jamie R. Blundell·Nature GeneticsPeer-reviewed·Sep 11, 2023